Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Medical Device Experts

Ken Powell, President
Ken Powell, President
Genesis Business Development, LLC
July 19, 2007
Point of Care
Analysis of: PreMD Signs Marketing and Distribution Agreement with AstraZeneca (www.pipelinereview.com)
Point of Care has many advantages.
Louis Rocco, System Director of Purchasing
Hallmark Health System, Inc
July 2, 2007
Comments
Analysis of: Mail order drugs flying off shelves (www.gazette.com)
I could not agree more that people should have a choice and maybe the pricing markey is the US will finally drop after how it see it will work all pharmacies across the country. The manufacturers need to be held responsible for this issue, they caused it with raising prices and making more of a profit....
Ken Powell, President
Ken Powell, President
Genesis Business Development, LLC
June 12, 2007
Cepheid's Value
Analysis of: New Test May Allow For Rapid Detection Of Salmonella In Meat (www.medicalnewstoday.com)
Cepheid http://finance.yahoo.com/q?s=CPHD has a unique platform technology that has the potential to move this company into a new realm of clinical diagnostics.
Ken Powell, President
Ken Powell, President
Genesis Business Development, LLC
Analysis of: E-records: 'Why is the U.S. so far behind?' (modernhealthcare.com)
*  Electronic medical records would yield a significant improvement in patient safety.  The Institute on Medicine report found that over 100,000 patients each year in the US die as a result of medical errors. *  Electronic medical records improve healthcare delivery quality and productivity...
David Berry, Director of Radiology
Medical College of Georgia
Analysis of: The Newest in Fluoroscopy Technology (www.dentalcompare.com)
Integrating the use of digital fluoroscopy to assist in Radiation Therapy planning could be quite useful in defining treatment area. Obviously, respiratory motion could impact on the location of the treatment site.  Observing and calculating the motion of organs would permit more precise treatment...
David Berry, Director of Radiology
Medical College of Georgia
June 11, 2007
Use of Fluroscopy
Analysis of: The Newest in Fluoroscopy Technology (www.dentalcompare.com)
There seems to be an increase in spinal surgeries and/or using C-arms.  It appears to this observer, that pain management services are increasing. With the digital technology present, radiation dose is less and the images can be interfaced with PACS.
Analysis of: FDA Approves XYZAL(R) (Levocetirizine Dihydrochloride) Tablets For The Relief Of Seasonal And Year Round Allergies, And Chronic Hives (www.medicalnewstoday.com)
Hismanal (R), approved by the FDA in the mid 1980's for the same indications as XYZAL, had similar properties (efficacy with one daily dose, low sedation, long elimination half-life, warning about dosing to renally impaired patients).  Hopefully, long-term studies with XYZAL will show neither...
Analysis of: Scrutiny of Stent Problems Turns to Doctors (online.wsj.com)
Many stents fail because of improper placement & deployment.  The interventional cardiologists must first select the proper size and rely heavily on the manufacturers technician/engineer.  They must also be placed properly to prevent migration and endo leaks and this is difficult without...
Mark Capriani, MBA, President and Chief Executive Officer
AciesHealth
Analysis of: FDA Approves XYZAL(R) (Levocetirizine Dihydrochloride) Tablets For The Relief Of Seasonal And Year Round Allergies, And Chronic Hives (www.medicalnewstoday.com)
FDA approval for UCB / Sanofi-Aventis new prescription drug Xyzal for treatment of seasonal and perennial comes at the perfect time for a big win for the pharmaceutical companies.  Xyzal has the potential to be the next blockbuster. The key questions:  Will physicians embrace the new med;...
Kenneth Edelson, Owner
Kenneth Edelson, MD
Analysis of: http://www.nytimes.com/2007/04/26/fashion/26skin.html?_r=1&ref=health&oref=slogin (www.nytimes.com)
All that glitters is not gold...but some might be! Anti-oxidants are the promise of saving our "hides"!

Previous Page : 3 4 5 6 7 8 9 10 11 12 13 14 15 Next121 to 130 of 148

Analytics


Generated at 2009-01-07T19:00:58.307